Abstract:In the 21st century, the trend of globalization expands widely and rapidly. As one of the most important drives, foreign direct investment (FDI) has been paid more and more attention for its effects on constructing the technological innovation capability and sustainable strategic competitiveness in the less developed countries. Now there are two different points of view on the effect from the entering FDI to the technological development in China: positive spillovers or negative spillovers. In fact the final result in the most of the empirical researches is an output mixed the two-sided effects. We can not only judge FDI by the final result, but also anatomize it. The research uses production function model based on panel data from 37 industrial enterprises in China from year 1998 to 2003. Most data comes from the yearbook of Chinese Industry and the yearbook of science and technology of China. It supposes that the technological spillovers follows the path from the FDI to the industrial innovative input which includes ″input structure″, ″input intensity″, then to the industrial innovative output which includes ″innovative effect″, ″innovative efficiency″, ″export competitive ability″, ″marginalization risk″. In the first part, the direct model discusses the relationship between innovative output and FDI. There are positive relationships between the entering of FDI and innovation effect, innovation efficiency and export in short time. But from the view of technological marginalization, FDI has strong influences on local companies' market reduction, technological dependence in the long run, and R&D capabilities' shrinking. In the second part, the indirect model discusses the relationship of the two innovative output variables mediated by innovative input intensity and innovative input structure. FDI impacts indirectly on innovative efficiency through influencing on innovative input intensity of the industry. And the structure of innovative fund source influences the usage efficiency of the fund and the innovative efficiency. It also partly moderates the relationship between FDI and innovative efficiency. In further study, it finds out that market growth, market competition and technological appropriation have partial mediating effects on the relationship between FDI and innovative input intensity of the industry.In summary, more and more technologies of the industries in China will come from outward sources in the future. The globalization of manufacturing has opened the opportunity window of learning for Chinese companies. And it brings big challenges at the same time.

The Comprehensive Influence of Firm-Level Factors on Drug Product Internationalization of Chinese Pharmaceutical Firms

A Study on the Effect of Spillovers of Foreign Direct Investment to Chinese Industrial Technological Innovation

International expansion and firm performance in emerging market: evidence from China

Research on the Influencing Factors, Paths and Effects of Chinese Enterprises' Internationalization Strategy

Exploring the Impact of Cross-side Network Interaction on Digital Platforms on Internationalization of Manufacturing Firms

Determinants on the Development of Internationalization in Chinese Enterprises: Evidence from Firm-level Survey data

Internet Penetration and Multi‐product Exporters: Firm‐level Evidence from China

Internationalization Strategies of Chinese Pharmaceutical Firms

Determinants of FDI Localization in China: A County-Level Analysis for the Pharmaceutical Industry

Untangling the Duality of Emerging Market Firms' Response to Outward Foreign Direct Investment Policies on Their Innovation Performance: A Resource Dependence Perspective

How is internationalised R&D influencing firms’ technological innovation: empirical results from China

Expanding to Outward Foreign Direct Investment or Not? A Multi-Dimensional Analysis of Entry Mode Transformation of Chinese Private Exporting Firms

The Regulatory Effect of Firm Size on Digital Transformation: An Empirical Study of Pharmaceutical Companies in China

The Determinants of the Choice of Innovation Source for Chinese Firms

Revolutionizing pharmaceutical innovation: Unveiling the impact of endogenous knowledge spillover in China

Digital technology application on corporate internationalization: Co-moderating effect of centralizing decision power and internationalization experience

Does China's centralized volume-based drug procurement policy facilitate the transition from imitation to innovation for listed pharmaceutical companies? Empirical tests based on double difference model

Determinants of Intra-Industry Pharmaceutical Trades in China and its Primary Global Partners

Study on the Effect of Internationalization on Innovation Ability of Firms in Emerging Markets---Based on the Interaction of Different Dimensions

Empirical Analysis of the Relationship between the Chinese Listed Companies' Degree of Internationalization and Operating Performance

Firm Productivity and Outbound Foreign Direct Investment: A Firm-Level Empirical Investigation of China